Literature DB >> 29501407

A novel mutation in sphingosine-1-phosphate lyase causing congenital brain malformation.

Daniel Bamborschke1, Matthias Pergande1, Kerstin Becker1, Friederike Koerber2, Jörg Dötsch3, Anne Vierzig3, Lutz T Weber3, Sebahattin Cirak4.   

Abstract

INTRODUCTION: Recently recessive mutations in sphingosine-1-phosphate lyase (SGPL1) have been published as a cause of syndromic congenital nephrotic syndrome with adrenal insufficiency. We have identified a case with fetal hydrops and brain malformations due to a mutation in SGPL1. CASE REPORT: We report a patient presenting with severe fetal hydrops, congenital nephrotic syndrome and adrenal calcifications. MRI imaging showed generalized cortical atrophy with simplified gyral pattern and hypoplastic temporal lobes as well as cerebellar hypoplasia and hyperintensity in the pons. The boy deceased at 6 weeks of age. Via whole exome sequencing, we identified a novel homozygous frameshift mutation c.1233delC (p.Phe411Leufs∗56) in SGPL1.
CONCLUSION: In our patient, we describe a novel mutation in sphingosine-1-phosphate lyase (SGPL1) leading to severe brain malformation. Neurodevelopmental phenotypes have been reported earlier, but not described in detail. To this end, we present a review on all published SGPL1-mutations and genotype-phenotype correlations focusing on neurodevelopmental outcomes. We hypothesized on the severe neurological phenotypes, which might be due to disruption of neuronal autophagy. Mutations in SGPL1 shall be considered in the differential diagnosis of fetal hydrops as well as congenital brain malformations and neuropathies.
Copyright © 2018 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebellar hypoplasia; Congenital brain malformation; Next generation sequencing; Sphingosine-1-phosphate lyase

Mesh:

Substances:

Year:  2018        PMID: 29501407     DOI: 10.1016/j.braindev.2018.02.008

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  21 in total

1.  SGPL1 Deficiency: A Rare Cause of Primary Adrenal Insufficiency.

Authors:  Nikolaos Settas; Rebecca Persky; Fabio R Faucz; Nicole Sheanon; Antonis Voutetakis; Maya Lodish; Louise A Metherell; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

Review 2.  Fifty years of lyase and a moment of truth: sphingosine phosphate lyase from discovery to disease.

Authors:  Julie D Saba
Journal:  J Lipid Res       Date:  2019-01-11       Impact factor: 5.922

3.  A rare cause of nephrotic syndrome-sphingosine-1-phosphate lyase (SGPL1) deficiency: 6 cases and a review of the literature.

Authors:  Tugba Tastemel Ozturk; Nur Canpolat; Seha Saygili; Umut Selda Bayrakci; Oguz Soylemezoglu; Fatih Ozaltin; Rezan Topaloglu
Journal:  Pediatr Nephrol       Date:  2022-06-24       Impact factor: 3.714

Review 4.  Congenital adrenal calcifications as the first clinical indication of sphingosine lyase insufficiency syndrome: A case report and review of the literature.

Authors:  Hayley A Ron; Rebecca Scobell; Amy Strong; Elizabeth G Salazar; Rebecca Ganetzky
Journal:  Am J Med Genet A       Date:  2022-08-16       Impact factor: 2.578

Review 5.  Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism.

Authors:  Youn-Jeong Choi; Julie D Saba
Journal:  Adv Biol Regul       Date:  2018-09-25

6.  MRI Spectrum of Brain Involvement in Sphingosine-1-Phosphate Lyase Insufficiency Syndrome.

Authors:  K W Martin; N Weaver; K Alhasan; E Gumus; B R Sullivan; M Zenker; F Hildebrandt; J D Saba
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-27       Impact factor: 3.825

7.  Loss of SMPD4 Causes a Developmental Disorder Characterized by Microcephaly and Congenital Arthrogryposis.

Authors:  Pamela Magini; Daphne J Smits; Laura Vandervore; Rachel Schot; Marta Columbaro; Esmee Kasteleijn; Mees van der Ent; Flavia Palombo; Maarten H Lequin; Marjolein Dremmen; Marie Claire Y de Wit; Mariasavina Severino; Maria Teresa Divizia; Pasquale Striano; Natalia Ordonez-Herrera; Amal Alhashem; Ahmed Al Fares; Malak Al Ghamdi; Arndt Rolfs; Peter Bauer; Jeroen Demmers; Frans W Verheijen; Martina Wilke; Marjon van Slegtenhorst; Peter J van der Spek; Marco Seri; Anna C Jansen; Rolf W Stottmann; Robert B Hufnagel; Robert J Hopkin; Deema Aljeaid; Wojciech Wiszniewski; Pawel Gawlinski; Milena Laure-Kamionowska; Fowzan S Alkuraya; Hanah Akleh; Valentina Stanley; Damir Musaev; Joseph G Gleeson; Maha S Zaki; Nicola Brunetti-Pierri; Gerarda Cappuccio; Bella Davidov; Lina Basel-Salmon; Lily Bazak; Noa Ruhrman Shahar; Aida Bertoli-Avella; Ghayda M Mirzaa; William B Dobyns; Tommaso Pippucci; Maarten Fornerod; Grazia M S Mancini
Journal:  Am J Hum Genet       Date:  2019-09-05       Impact factor: 11.025

8.  Responsiveness of sphingosine phosphate lyase insufficiency syndrome to vitamin B6 cofactor supplementation.

Authors:  Piming Zhao; Isaac D Liu; Jeffrey B Hodgin; Peter I Benke; Jeremy Selva; Federico Torta; Markus R Wenk; James A Endrizzi; Olivia West; Weixing Ou; Emily Tang; Denise Li-Meng Goh; Stacey Kiat-Hong Tay; Hui-Kim Yap; Alwin Loh; Nicole Weaver; Bonnie Sullivan; Austin Larson; Megan A Cooper; Khalid Alhasan; Abdullah A Alangari; Suha Salim; Evren Gumus; Karin Chen; Martin Zenker; Friedhelm Hildebrandt; Julie D Saba
Journal:  J Inherit Metab Dis       Date:  2020-05-04       Impact factor: 4.982

9.  Efficacy of AAV9-mediated SGPL1 gene transfer in a mouse model of S1P lyase insufficiency syndrome.

Authors:  Piming Zhao; Gizachew B Tassew; Joanna Y Lee; Babak Oskouian; Denise P Muñoz; Jeffrey B Hodgin; Gordon L Watson; Felicia Tang; Jen-Yeu Wang; Jinghui Luo; Yingbao Yang; Sarah King; Ronald M Krauss; Nancy Keller; Julie D Saba
Journal:  JCI Insight       Date:  2021-04-22

Review 10.  Genotype/Phenotype Interactions and First Steps Toward Targeted Therapy for Sphingosine Phosphate Lyase Insufficiency Syndrome.

Authors:  Julie D Saba; Nancy Keller; Jen-Yeu Wang; Felicia Tang; Avi Slavin; Yizhuo Shen
Journal:  Cell Biochem Biophys       Date:  2021-06-16       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.